Thursday, August 31, 2017

Ecstasy now FDA Breakthrough Drug for PTSD

Ecstasy Was Just Labelled a 'Breakthrough Therapy' For PTSD by The FDA.  We are now that much closer to stage 3 clinical trials for MDMA.

This on the heels of recent research showing that MDMA facilitates changes in basic personality traits such as openness and neuroticism, traits that were previously thought to be fixed in adults until psilocybin was shown to make people more open.

No comments:

Post a Comment